Navana Pharmaceuticals Balance Sheet

Financials in millions BDT. Fiscal year is July - June.

Millions BDT. Fiscal year is Jul - Jun.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Cash & Equivalents	208.61	184.53	267.77	440.93	66.43	25.78
Cash & Short-Term Investments	208.61	184.53	267.77	440.93	66.43	25.78
Cash Growth	-26.17%	-31.09%	-39.27%	563.78%	157.71%	-52.89%
Accounts Receivable	1,275	1,360	996.56	788.15	519.97	434.81
Other Receivables	29.5	16.12	23.57	13.09	27.85	28.08
Receivables	1,305	1,376	1,020	801.24	547.82	462.89
Inventory	2,266	2,086	2,303	1,554	1,170	931.44
Prepaid Expenses	-	-	-	0.95	2.59	1.98
Other Current Assets	1,566	1,536	1,890	1,993	1,109	387.04
Total Current Assets	5,345	5,182	5,480	4,789	2,895	1,809
Property, Plant & Equipment	6,130	6,256	5,746	4,632	4,029	3,389
Long-Term Investments	42.44	34.46	76.92	167.62	159.03	-
Other Intangible Assets	-	0.11	0.33	0.55	0.77	0.99
Other Long-Term Assets	0	-	-	-	-	0
Total Assets	11,518	11,472	11,304	9,590	7,084	5,199
Accounts Payable	82.53	83.92	23.79	44.46	42.65	20.43
Accrued Expenses	674.23	639.15	444.32	298.32	245.36	185.09
Short-Term Debt	3,834	4,283	5,008	4,066	2,682	1,143
Current Portion of Long-Term Debt	46.41	85.76	35.37	18.09	28.13	18.8
Current Portion of Leases	40.23	45.85	43.55	34.72	29.25	34.62
Current Income Taxes Payable	744.45	616.02	451.2	345.48	245.11	141.44
Other Current Liabilities	350.26	292.67	288.36	47.84	14.02	28.31
Total Current Liabilities	5,772	6,047	6,295	4,855	3,287	1,572
Long-Term Debt	112.44	118.66	225.32	120.63	171.39	162.98
Long-Term Leases	111.36	115.35	64.5	89.6	100.72	131.53
Long-Term Deferred Tax Liabilities	331.19	326.71	158.01	152.11	42.36	28.25
Other Long-Term Liabilities	0	-	-	0	-	-0
Total Liabilities	6,327	6,607	6,743	5,217	3,601	1,895
Common Stock	1,074	1,074	1,074	1,074	802.3	802.3
Additional Paid-In Capital	448.17	448.17	448.17	448.17	-	-
Retained Earnings	1,463	1,148	708.02	443.03	204.24	535.83
Comprehensive Income & Other	2,205	2,194	2,331	2,407	2,477	1,966
Shareholders' Equity	5,191	4,865	4,561	4,372	3,483	3,304
Total Liabilities & Equity	11,518	11,472	11,304	9,590	7,084	5,199
Total Debt	4,145	4,649	5,377	4,329	3,012	1,491
Net Cash (Debt)	-3,894	-4,430	-5,032	-3,721	-2,786	-1,466
Net Cash Per Share	-36.09	-41.24	-46.85	-37.42	-34.73	-18.27
Filing Date Shares Outstanding	107.42	107.42	107.42	107.42	80.23	80.23
Total Common Shares Outstanding	107.42	107.42	107.42	107.42	80.23	80.23
Working Capital	-426.95	-864.47	-814.39	-65.55	-391.14	237.08
Book Value Per Share	48.32	45.29	42.46	40.71	43.41	41.19
Tangible Book Value	5,191	4,865	4,561	4,372	3,482	3,303
Tangible Book Value Per Share	48.32	45.29	42.46	40.70	43.40	41.17
Land	2,483	2,483	2,483	2,483	2,483	2,483
Buildings	1,852	1,700	1,415	1,142	745.82	231.9
Machinery	2,342	2,330	1,708	985.02	831.81	789.03
Construction In Progress	692.73	821.13	931.72	614.67	403.01	159.04

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.